U.S. CarMax, Eli Lilly, MicroStrategy
June 24 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CarMax, Eli Lilly and MicroStrategy, on Monday.
HIGHLIGHTS
* CarMax Inc KMX.N: RBC raises target price to $75 from $73 |
* Eli Lilly LLY.N: Jefferies raises target price to $1,015 from $994 |
* MicroStrategy Inc MSTR.O: Canaccord Genuity cuts target price to $1,826 from $2,047 |
* Sharecare Inc SHCR.O: Canaccord Genuity cuts to hold from buy |
* Thermo Fisher Scientific Inc TMO.N: RBC cuts target price to $660 from $662 |
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* Aethlon Medical Inc AEMD.O: H.C. Wainwright cuts target price to $7 from $10 |
* Affirm Holdings AFRM.O: Goldman Sachs assumes coverage with buy vs neutral rating; PT $42 vs $21 |
* Agilysys Inc AGYS.O: William Blair initiates coverage with outperform rating |
* Ally Financial Inc ALLY.N: Citigroup initiates coverage with buy rating; PT $50 |
* Alnylam Pharmaceuticals Inc ALNY.O: Piper Sandler raises target price to $264 from $217 |
* Ameren Corp AEE.N: BMO cuts target price to $80 from $81 |
* Apple Inc AAPL.O: Melius Research raises target price to $260 from $227 |
* Arcus Biosciences Inc RCUS.N: Truist Securities cuts target price to $44 from $50 |
* Argenx SE ARGX.O: Stifel raises target price to $500 from $485 |
* Associated Banc-Corp ASB.N: Barclays cuts target price to $22 from $24 |
* AT&T Inc T.N: HSBC raises target price to $22 from $20.5 |
* Avalonbay Communities Inc AVB.N: Truist Securities raises PT to $213 from $207 |
* Bankunited Inc BKU.N: Citigroup raises target price to $30 from $28 |
* Bankunited, Inc. BKU.N: Barclays raises target price to $30 from $29 |
* Bio Rad Laboratories Inc BIO.N: RBC cuts target price to $402 from $414 |
* Block Inc SQ.N: Goldman Sachs assumes coverage with buy rating; PT $80 vs $94 |
* BOK Financial Corp BOKF.O: Citigroup cuts target price to $96 from $100 |
* BOK Financial Corp BOKF.O: Wedbush raises target price to $101 from $100 |
* Broadcom Inc AVGO.O: BofA Global Research raises PT to $2150 from $2000 |
* Cadence Bank CADE.N: Barclays raises target price to $30 from $29 |
* Cadence Bank CADE.N: Citigroup cuts target price to $30 from $32 |
* Camden Property Trust CPT.N: Truist Securities raises target price to $122 from $114 |
* Carmax Inc KMX.N: Needham cuts target price to $87 from $91 |
* CarMax Inc KMX.N: RBC raises target price to $75 from $73 |
* Carmax Inc KMX.N: Truist Securities raises target price to $70 from $66 |
* Carmax Inc KMX.N: Wedbush cuts target price to $85 from $90 |
* Carrier Global Corp CARR.N: Citigroup raises target price to $74 from $65 |
* Carrier Global Corp CARR.N: Citigroup raises to buy from neutral |
* Chart Industries GTLS.N: Raymond James adds stock to its analyst current favorites list |
* Cheniere Energy Inc LNG.N: Jefferies raises target price to $220 from $217 |
* Cinemark Holdings Inc CNK.N: Roth MKM raises target price to $26 from $19 |
* Cinemark Holdings Inc CNK.N: Roth MKM raises to buy from neutral |
* Columbia Banking System Inc COLB.O: Citigroup cuts target price to $19 from $20 |
* Comcast Corp CMCSA.O: Seaport Research Partners cuts to neutral from buy |
* Comerica Inc CMA.N: Citigroup cuts target price to $50 from $56 |
* Comerica Inc CMA.N: Wedbush cuts target price to $56 from $57 |
* Corpay Inc. CPAY.N: Barclays cuts target price to $330 from $350 |
* Cryoport Inc CYRX.O: Leerink Partners cuts target price to $15 from $17 |
* Cullen/Frost Bankers Inc CFR.N: Citigroup cuts target price to $93 from $103 |
* Cytokinetics Inc CYTK.O: JP Morgan cuts target price to $65 from $77 |
* Dayforce Inc DAY.N: Jefferies cuts target price to $55 from $60 |
* Digimarc Corp DMRC.O: Needham raises to buy from hold |
* Digital Realty Trust Inc DLR.N: Jefferies raises target price to $185 from $175 |
* East West Bancorp Inc EWBC.O: Citigroup cuts target price to $87 from $91 |
* East West Bancorp, Inc. EWBC.O: Barclays cuts target price to $105 from $106 |
* Electronic Arts Inc EA.O: Stifel raises target price to $163 from $150 |
* Element Solutions Inc ESI.N: UBS raises target price to $33 from $30 |
* Eli Lilly LLY.N: Jefferies raises target price to $1,015 from $994 |
* Enviri Corp NVRI.N: BMO raises target price to $9 from $8.50 |
* Envoy Medical COCH.O: Ascendiant Capital Markets initiates coverage with buy rating |
* Envoy Medical COCH.O: Ascendiant Capital Markets initiates coverage with PT $8.5 |
* Equity Residential EQR.N: Truist Securities raises target price to $73 from $67 |
* Essex Property Trust Inc ESS.N: Truist Securities raises PT to $282 from $255 |
* Factset Research Systems Inc FDS.N: Deutsche Bank raises PT to $461 from $457 |
* Factset Research Systems Inc FDS.N: Jefferies raises target price to $425 from $378 |
* Fedex Corp FDX.N: Evercore ISI cuts target price to $318 from $351 |
* Fedex Corp FDX.N: Raymond James cuts target price to $300 from $325 |
* Fifth Third Bancorp FITB.O: Wedbush raises target price to $45 from $44 |
* First Hawaiian, Inc. FHB.O: Barclays cuts target price to $24 from $25 |
* First Horizon Corp FHN.N: Wedbush raises target price to $18 from $17 |
* First Horizon Corporation FHN.N: Barclays raises target price to $19 from $18 |
* G1 Therapeutics Inc GTHX.O: Wedbush cuts target price to $3 from $5 |
* Gilead GILD.O: Jefferies raises target price to $85 from $80 |
* Graham Corp GHM.N: Noble Capital initiates coverage with outperform rating; PT $35 |
* Hamilton Lane Inc HLNE.O: UBS raises target price to $122 from $120 |
* Heico Corp HEI.N: BofA Global Research raises price objective to $250 from $220 |
* Home Bancshares Inc HOMB.N: Citigroup cuts target price to $24 from $26 |
* Huntington Bancshares Inc HBAN.O: Wedbush cuts target price to $13 from $14 |
* Hut 8 Corp HUT.O: Needham raises target price to $15 from $13 |
* ICF International Inc ICFI.O: William Blair raises to outperform |
* Idexx Laboratories Inc IDXX.O: Stifel cuts target price to $510 from $520 |
* Inspire Medical Systems Inc INSP.N: Stifel cuts target price to $170 from $210 |
* International Flavors & Fragrances Inc IFF.N: Jefferies raises PT to $111 from $110 |
* Jbg Smith Properties JBGS.N: BMO cuts target price to $17 from $18 |
* KB Home KBH.N: JP Morgan raises target price to $75 from $70.50 |
* Kroger Co KR.N: Morgan Stanley cuts target price to $57 from $58 |
* Leidos Holdings Inc LDOS.N: Stifel raises target price to $165 from $160 |
* Levi Strauss & Co LEVI.N: Stifel raises target price to $28 from $24 |
* M&T Bank Corp MTB.N: Wedbush cuts target price to $167 from $170 |
* Marathon Petroleum Corp MPC.N: Jefferies raises target price to $222 from $217 |
* Marqeta Inc MQ.O: Goldman Sachs assumes coverage with neutral rating; PT $5.5 vs $6 |
* McCormick & Company Inc MKC.N: TD Cowen cuts target price to $73 from $75 |
* Micron Technology Inc MU.O: Citigroup raises target price to $175 from $150 |
* MicroStrategy Inc MSTR.O: Canaccord Genuity cuts target price to $1,826 from $2,047 |
* Mid-America Apartment Communities MAA.N: Truist Securities raises PT to $156 from $148 |
* New York Community Bancorp NYCB.N: Barclays cuts target price to $4 from $5 |
* Nexpoint Residential Trust Inc NXRT.N: Truist Securities raises PT to $37 from $34 |
* Nu Holdings Ltd NU.N: Jefferies raises target price to $15.2 from $10.8 |
* Nvidia Corp NVDA.O: Jefferies raises target price to $150 from $135 |
* Nyxoah SA NYXH.O: Stifel cuts target price to $19 from $27 |
* Old Dominion Freight Line Inc ODFL.O: Raymond James cuts PT to $190 from $215 |
* Old National Bancorp ONB.O: Barclays raises target price to $22 from $21 |
* Paycom Software Inc PAYC.N: Jefferies cuts target price to $145 from $170 |
* Paycor HCM Inc PYCR.O: Jefferies cuts target price to $11 from $14 |
* Paylocity Holding Corp PCTY.O: Jefferies cuts target price to $145 from $180 |
* PayPal PYPL.O: Goldman Sachs assumes coverage with neutral vs buy rating; PT $69 vs $76 |
* Pepsico Inc PEP.O: Deutsche Bank cuts target price to $180 from $185 |
* Phillips 66 PSX.N: Jefferies cuts target price to $137 from $156 |
* Pinnacle Financial Partners Inc PNFP.O: Citigroup cuts target price to $93 from $98 |
* Planet Fitness Inc PLNT.N: TD Cowen raises target price to $92 from $66 |
* Planet Fitness Inc PLNT.N: TD Cowen raises to buy from hold |
* Popular Inc BPOP.O: Citigroup cuts target price to $110 from $113 |
* Popular, Inc. BPOP.O: Barclays cuts target price to $103 from $105 |
* Praxis Precision Medicines PRAX.O: Needham initiates coverage with buy rating; PT $145 |
* Prosperity Bancshares Inc PB.N: Citigroup cuts target price to $66 from $76 |
* Quidelortho Corp QDEL.O: RBC cuts target price to $61 from $68 |
* Repligen Corp RGEN.O: RBC cuts target price to $190 from $221 |
* Royal Caribbean Group RCL.N: JP Morgan raises target price to $175 from $173 |
* Rxo Inc RXO.N: TD Cowen raises target price to $23 from $20 |
* Saia Inc SAIA.O: Raymond James cuts target price to $520 from $540 |
* Sarepta Therapeutics Inc SRPT.O: BMO raises target price to $200 from $170 |
* Sarepta Therapeutics Inc SRPT.O: Evercore ISI raises target price to $185 from $139 |
* Sarepta Therapeutics Inc SRPT.O: JP Morgan raises target price to $205 from $175 |
* Sarepta Therapeutics Inc SRPT.O: Leerink Partners raises PT to $230 from $165 |
* Sarepta Therapeutics Inc SRPT.O: Mizuho raises target price to $200 from $179 |
* Sharecare Inc SHCR.O: Canaccord Genuity cuts target price to $1.43 from $2 |
* Sharecare Inc SHCR.O: Canaccord Genuity cuts to hold from buy |
* Sharecare Inc SHCR.O: Morgan Stanley raises target price to $1.43 from $1 |
* Site Centers Corp SITC.N: Jefferies raises target price to $15 from $14 |
* Solid Biosciences SLDB.O: Leerink Partners raises to outperform from market perform |
* Stepstone Group Inc STEP.O: UBS raises target price to $44 from $38 |
* Synovus Financial Corp SNV.N: Barclays raises target price to $46 from $39 |
* Synovus Financial Corp SNV.N: Barclays raises to overweight from equal weight |
* Sysco Corp SYY.N: Truist Securities cuts target price to $85 from $87 |
* Tectonic Therapeutic Inc TECX.O: TD Cowen initiates coverage with buy rating |
* Texas Capital Bancshares Inc TCBI.O: Citigroup cuts target price to $60 from $61 |
* Thermo Fisher Scientific Inc TMO.N: RBC cuts target price to $660 from $662 |
* T-Mobile Us Inc TMUS.O: HSBC raises target price to $195 from $180 |
* UDR Inc UDR.N: Truist Securities raises target price to $44 from $42 |
* UMB Financial Corporation UMBF.O: Barclays raises target price to $100 from $95 |
* under Armour Inc UAA.N: Stifel cuts target price to $9 from $10 |
* UPS UPS.N: Evercore ISI cuts target price to $145 from $157 |
* Valero Energy Corp VLO.N: Jefferies cuts target price to $184 from $188 |
* Valley National Bancorp VLY.O: Barclays cuts target price to $7 from $8 |
* Valley National Bancorp VLY.O: Citigroup cuts target price to $7 from $8.5 |
* Veris Residential Inc VRE.N: Truist Securities cuts target price to $14 from $15 |
* Verizon Communications VZ.N: HSBC raises target price to $44 from $42 |
* Vertex Pharmaceuticals Incorporated VRTX.O: Wells Fargo raises PT to $555 from $540 |
* Vince Holding Corp VNCE.N: Noble Capital initiates coverage with outperform rating; PT $3 |
* Vista Gold Corp. VGZ.A: H.C. Wainwright raises target price to $2.75 from $2.5 |
* Walgreens WBA.O: UBS cuts target price to $17 from $22 |
* Walgreens Boots Alliance WBA.O: Barclays cuts target price to $15 from $21 |
* Webster Financial Corp WBS.N: Citigroup cuts target price to $49 from $55 |
* Webster Financial Corporation WBS.N: Barclays cuts target price to $60 from $65 |
* Western Alliance Bancorp WAL.N: Jefferies cuts target price to $70 from $71 |
* Wintrust Financial Corp WTFC.O: Citigroup cuts target price to $110 from $113 |
* Workhorse Group Inc WKHS.O: TD Cowen raises target price to $3 from $0.35 |
* XPO Inc XPO.N: Raymond James cuts target price to $130 from $135 |
* Zeta Global Holdings Corp ZETA.N: BofA Global Research raises PT to $20 from $18 |
(Compiled by Bengaluru Newsroom)
</body></html>Activos relacionados
Últimas noticias
Descargo de responsabilidades: Cada una de las entidades de XM Group proporciona un servicio de solo ejecución y acceso a nuestra plataforma de trading online, permitiendo a una persona ver o usar el contenido disponible en o a través del sitio web, sin intención de cambiarlo ni ampliarlo. Dicho acceso y uso están sujetos en todo momento a: (i) Términos y Condiciones; (ii) Advertencias de riesgo; y (iii) Descargo completo de responsabilidades. Por lo tanto, dicho contenido se proporciona exclusivamente como información general. En particular, por favor tenga en cuenta que, los contenidos de nuestra plataforma de trading online no son ni solicitud ni una oferta para entrar a realizar transacciones en los mercados financieros. Operar en cualquier mercado financiero implica un nivel de riesgo significativo para su capital.
Todo el material publicado en nuestra plataforma de trading online tiene únicamente fines educativos/informativos y no contiene –y no debe considerarse que contenga– asesoramiento ni recomendaciones financieras, tributarias o de inversión, ni un registro de nuestros precios de trading, ni una oferta ni solicitud de transacción con instrumentos financieros ni promociones financieras no solicitadas.
Cualquier contenido de terceros, así como el contenido preparado por XM, como por ejemplo opiniones, noticias, investigaciones, análisis, precios, otras informaciones o enlaces a sitios de terceros que figuran en este sitio web se proporcionan “tal cual”, como comentarios generales del mercado y no constituyen un asesoramiento en materia de inversión. En la medida en que cualquier contenido se interprete como investigación de inversión, usted debe tener en cuenta y aceptar que dicho contenido no fue concebido ni elaborado de acuerdo con los requisitos legales diseñados para promover la independencia en materia de investigación de inversiones y, por tanto, se considera como una comunicación comercial en virtud de las leyes y regulaciones pertinentes. Por favor, asegúrese de haber leído y comprendido nuestro Aviso sobre investigación de inversión no independiente y advertencia de riesgo en relación con la información anterior, al que se puede acceder aquí.